NCT03716466

Brief Summary

Upper gastrointestinal (GI) bleeding is defined as patients who either presented with hematemesis or presented with melena along with evidence of hemodynamic compromise. These patients have risk of aspiration of blood along with gastric content. The mortality rate can be 15% to 20% in the cases with variceal bleeding. From a practical standpoint, it is widely accepted that the best way to secure an airway during upper GI bleeding is prophylactic endotracheal intubation (PEI). The aim of this study is to determine the incidence of complications among critically ill patients with upper GI bleeding and received urgent endoscopy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2018

Completed
25 days until next milestone

First Posted

Study publicly available on registry

October 23, 2018

Completed
19 days until next milestone

Study Start

First participant enrolled

November 11, 2018

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2018

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 9, 2021

Completed
Last Updated

May 23, 2022

Status Verified

May 1, 2022

Enrollment Period

25 days

First QC Date

September 28, 2018

Last Update Submit

May 16, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardiovascular unplanned event

    The number of cardiovascular unplanned event after upper gastrointestinal endoscopy, up to 48 hours

    Postoperative up to 48 hours

Secondary Outcomes (1)

  • Pulmonary unplanned event

    Postoperative up to 48 hours

Study Arms (2)

Endotracheal intubation

Cases with prophylactic endotracheal intubation during urgent endoscopy procedure for upper gastrointestinal bleeding .

Other: Endotracheal intubation

No airway intervention

Cases without airway intervention during urgent endoscopy procedure for upper gastrointestinal bleeding

Other: No airway intervention

Interventions

Subjects will receive prophylactic endotracheal intubation for upper gastrointestinal endoscopy procedure

Endotracheal intubation

Subjects without prophylactic endotracheal intubation during upper gastrointestinal endoscopy procedure

No airway intervention

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cases with upper gastrointestinal bleeding.

You may qualify if:

  • Age 18 years and older
  • Presence of upper gastrointestinal bleeding either presented with hematemesis or melena along with evidence of hemodynamic compromise.
  • Received procedural (conscious) sedation
  • Undergoing urgent upper gastrointestinal endoscopy procedures

You may not qualify if:

  • Intubation other than airway protection
  • Prior tracheostomy before onset of gastrointestinal bleeding
  • Subjects intubated before transfer to gastrointestinal suite
  • Subjects without hemodynamic instability
  • Subjects with a diagnosis of pneumonia, acute respiratory distress syndrome, myocardial infarction, pulmonary edema, arrhythmia, or cardiac arrest before endoscopy
  • Endoscopy done for other than upper gastrointestinal bleeding
  • Pregnant subjects

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parkland Health Hospital System

Dallas, Texas, 750390, United States

Location

MeSH Terms

Conditions

Gastrointestinal Hemorrhage

Interventions

Intubation, Intratracheal

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Airway ManagementTherapeuticsIntubationInvestigative Techniques

Study Officials

  • David Nasir, MD

    214-590-5352

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ASSOC PROFESSOR

Study Record Dates

First Submitted

September 28, 2018

First Posted

October 23, 2018

Study Start

November 11, 2018

Primary Completion

December 6, 2018

Study Completion

July 9, 2021

Last Updated

May 23, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations